And it was consistent that the mean 1153.35 ± 397.42 pg/ml serum STC2 in CRC patients was 3.5-folds of 331.08 ± 184.17 pg/ml level in healthy persons (P < 0.001, Figure 8B). This evidence concerns the gene STC2 and colorectal carcinoma.